Laboratory Question for the Week of July 20, 2020

Laboratory Compliance Question of the Week


Is it true that CMS will increase payment for COVID-19 specific lab tests?


The Centers for Medicare & Medicaid Services (CMS) announced on April 15, that Medicare will be offering almost double the payment for specific COVID-19 lab tests accomplished through high-throughput technologies to expedite the diagnosis of large numbers of COVID-19 cases. The policy aims to expand testing to the public and particularly for Medicare patients who remain among the nation’s most vulnerable, and impacted, such as nursing home residents. This announcement is part of a multitude of actions to expand COVID-19 testing. Medicare will now reimburse the tests at a higher rate of $100 for COVID-19 clinical diagnostic lab tests “making use of high-throughput technologies developed by the private sector that allow for increased testing capacity, faster results, and more effective means of combating the spread of the virus.”

This question was answered in an edition of our Laboratory Compliance Manager. For more hot topics relating to laboratory services, please visit our store or call us at 1.800.252.1578, ext. 2.

CPT© copyright 2020 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.